• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双重靶向抗凋亡蛋白增强急性髓系白血病细胞的化疗敏感性。

Dual Targeting of Anti-Apoptotic Proteins Enhances Chemosensitivity of the Acute Myeloid Leukemia Cells.

机构信息

Immunology Research Center, Tabriz University of Medical sciences, Tabriz, Iran.

Department of Immunology, Faculty of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran.

出版信息

Asian Pac J Cancer Prev. 2022 Jul 1;23(7):2523-2530. doi: 10.31557/APJCP.2022.23.7.2523.

DOI:10.31557/APJCP.2022.23.7.2523
PMID:35901361
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9727342/
Abstract

BACKGROUND

Acute myeloid leukemia (AML) is a type of blood cancer characterized by fast cellular proliferation. Myeloid cell leukemia-1 (Mcl-1) and survivin, as anti-apoptotic proteins, are involved in cancer growth and resistance to chemotherapy. The aim of this study was to examine the combination effect of Mcl-1 and survivin specific siRNAs on chemosensitivity of the human HL-60 AML cells.

METHODS

SiRNAs transfection was performed by using Lipofectamine™2000 reagent. The mRNA expression was analyzed by real-time quantitative PCR. The apoptosis analysis was measured by ELISA cell death assay.

RESULTS

siRNAs markedly suppressed mRNA expression levels of Mcl-1 and survivin in a time-dependent manner, resulting in reduction of leukemic cell proliferation and enhanced spontaneous cell death. Surprisingly, Mcl-1 siRNA and survivin siRNA synergistically enhanced the cell toxic effects of etoposide. Furthermore, down-regulation of Mcl-1 and survivin significantly enhanced the apoptotic effect of etoposide.

CONCLUSIONS

Our investigation suggests that suppression of Mcl-1 and survivin by siRNA can effectually inhibit cell growth and overcome chemoresistance of AML cells. Therefore siRNAs may be an important adjuvant in chemotherapy for AML patients.

摘要

背景

急性髓细胞白血病(AML)是一种以细胞快速增殖为特征的血液癌症。髓样细胞白血病-1(Mcl-1)和存活素作为抗凋亡蛋白,参与癌症的生长和对化疗的耐药性。本研究旨在研究 Mcl-1 和存活素特异性 siRNA 的联合作用对人 HL-60 AML 细胞化疗敏感性的影响。

方法

通过 Lipofectamine™2000 试剂进行 siRNA 转染。通过实时定量 PCR 分析 mRNA 表达。通过 ELISA 细胞死亡测定法测量细胞凋亡。

结果

siRNA 显著抑制 Mcl-1 和存活素的 mRNA 表达水平,呈时间依赖性,导致白血病细胞增殖减少和自发细胞死亡增加。令人惊讶的是,Mcl-1 siRNA 和 survivin siRNA 协同增强依托泊苷的细胞毒性作用。此外,下调 Mcl-1 和 survivin 显著增强了依托泊苷的促凋亡作用。

结论

我们的研究表明,siRNA 抑制 Mcl-1 和 survivin 可以有效地抑制细胞生长并克服 AML 细胞的化疗耐药性。因此,siRNA 可能是 AML 患者化疗的重要辅助手段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30d1/9727342/02cb65bffc67/APJCP-23-2523-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30d1/9727342/909183ae6433/APJCP-23-2523-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30d1/9727342/2bd5ca58bc15/APJCP-23-2523-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30d1/9727342/0d32bffd62ee/APJCP-23-2523-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30d1/9727342/02cb65bffc67/APJCP-23-2523-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30d1/9727342/909183ae6433/APJCP-23-2523-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30d1/9727342/2bd5ca58bc15/APJCP-23-2523-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30d1/9727342/0d32bffd62ee/APJCP-23-2523-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30d1/9727342/02cb65bffc67/APJCP-23-2523-g004.jpg

相似文献

1
Dual Targeting of Anti-Apoptotic Proteins Enhances Chemosensitivity of the Acute Myeloid Leukemia Cells.双重靶向抗凋亡蛋白增强急性髓系白血病细胞的化疗敏感性。
Asian Pac J Cancer Prev. 2022 Jul 1;23(7):2523-2530. doi: 10.31557/APJCP.2022.23.7.2523.
2
siRNA-mediated silencing of survivin inhibits proliferation and enhances etoposide chemosensitivity in acute myeloid leukemia cells.小干扰RNA介导的生存素沉默抑制急性髓系白血病细胞增殖并增强依托泊苷化疗敏感性。
Asian Pac J Cancer Prev. 2013;14(12):7719-24. doi: 10.7314/apjcp.2013.14.12.7719.
3
Enhancement of chemosensitivity by simultaneously silencing of Mcl-1 and Survivin genes using small interfering RNA in human myelomonocytic leukaemia.利用小干扰 RNA 同时沉默 Mcl-1 和 Survivin 基因增强人髓单核白血病的化疗敏感性。
Artif Cells Nanomed Biotechnol. 2018 Dec;46(8):1792-1798. doi: 10.1080/21691401.2017.1392969. Epub 2017 Nov 7.
4
Down-regulation of Mcl-1 by small interference RNA induces apoptosis and sensitizes HL-60 leukemia cells to etoposide.小干扰RNA下调Mcl-1可诱导HL-60白血病细胞凋亡并使其对依托泊苷敏感。
Asian Pac J Cancer Prev. 2014;15(2):629-35. doi: 10.7314/apjcp.2014.15.2.629.
5
siRNA-mediated inhibition of survivin gene enhances the anti-cancer effect of etoposide in U-937 acute myeloid leukemia cells.小干扰RNA介导的生存素基因抑制增强了依托泊苷对U-937急性髓系白血病细胞的抗癌作用。
Cell Mol Biol (Noisy-le-grand). 2016 May 30;62(6):44-9.
6
Silencing of myeloid cell leukemia-1 by small interfering RNA improves chemosensitivity to etoposide in u-937 leukemic cells.小干扰RNA沉默髓样细胞白血病-1可提高U-937白血病细胞对依托泊苷的化疗敏感性。
J Biol Regul Homeost Agents. 2016 Jan-Mar;30(1):55-65.
7
Therapeutic Effects of Myeloid Cell Leukemia-1 siRNA on Human Acute Myeloid Leukemia Cells.髓系细胞白血病-1小干扰RNA对人急性髓系白血病细胞的治疗作用
Adv Pharm Bull. 2014;4(3):243-8. doi: 10.5681/apb.2014.035. Epub 2014 Feb 7.
8
Reversal of chemoresistance with small interference RNA (siRNA) in etoposide resistant acute myeloid leukemia cells (HL-60).用小干扰 RNA(siRNA)逆转依托泊苷耐药急性髓系白血病细胞(HL-60)中的耐药性。
Biomed Pharmacother. 2015 Oct;75:100-4. doi: 10.1016/j.biopha.2015.08.032. Epub 2015 Sep 25.
9
Influence of survivin-targeted therapy on chemosensitivity in the treatment of acute myeloid leukemia.生存素靶向治疗对急性髓系白血病治疗中化疗敏感性的影响。
Cancer Lett. 2015 Oct 1;366(2):160-72. doi: 10.1016/j.canlet.2015.05.033. Epub 2015 Jun 26.
10
Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells.索拉非尼抑制Mcl-1可加速全反式维甲酸诱导的分化反应性急性髓系白血病细胞凋亡。
Clin Cancer Res. 2016 Mar 1;22(5):1211-21. doi: 10.1158/1078-0432.CCR-15-0663. Epub 2015 Oct 12.

引用本文的文献

1
Enhancement of the Sensitivity of the Acute Lymphoblastic Leukemia Cells to ABT-737 by Formononetin.芒柄花素增强急性淋巴细胞白血病细胞对ABT-737的敏感性
Int J Mol Cell Med. 2024;13(3):259-271. doi: 10.22088/IJMCM.BUMS.13.3.259.
2
Formononetin and Dihydroartemisinin Act Synergistically to Induce Apoptosis in Human Acute Myeloid Leukemia Cell Lines.芒柄花黄素与双氢青蒿素协同作用诱导人急性髓系白血病细胞系凋亡。
Cell J. 2024 Feb 1;26(2):121-129. doi: 10.22074/cellj.2024.2016937.1459.
3
The Effects of ABT-199 and Dihydroartemisinin Combination on Cell Growth and Apoptosis in Human U937 and KG-1 Cancer Cells.

本文引用的文献

1
Cotargeting of Bcl-2 and Mcl-1 shows promising antileukemic activity against AML cells including those with acquired cytarabine resistance.同时靶向Bcl-2和Mcl-1对急性髓系白血病细胞(包括那些获得阿糖胞苷耐药性的细胞)显示出有前景的抗白血病活性。
Exp Hematol. 2022 Jan;105:39-49. doi: 10.1016/j.exphem.2021.10.006. Epub 2021 Nov 9.
2
MicroRNA-138 Increases Chemo-Sensitivity of Glioblastoma through Downregulation of Survivin.微小RNA-138通过下调生存素增加胶质母细胞瘤的化疗敏感性。
Biomedicines. 2021 Jul 6;9(7):780. doi: 10.3390/biomedicines9070780.
3
MiRNA-Mediated Knock-Down of Bcl-2 and Mcl-1 Increases Fludarabine-Sensitivity in CLL-CII Cells.
ABT-199 和双氢青蒿素联合用药对人 U937 和 KG-1 癌细胞生长和凋亡的影响。
Asian Pac J Cancer Prev. 2024 Jan 1;25(1):343-350. doi: 10.31557/APJCP.2024.25.1.343.
4
Dihydroartemisinin Enhances the Therapeutic Efficacy of BH3 Mimetic Inhibitor in Acute Lymphoblastic Leukemia Cells via Inhibition of Mcl-1.双氢青蒿素通过抑制 Mcl-1 增强 BH3 模拟物抑制剂在急性淋巴细胞白血病细胞中的治疗效果。
Asian Pac J Cancer Prev. 2024 Jan 1;25(1):325-332. doi: 10.31557/APJCP.2024.25.1.325.
miRNA 介导的 Bcl-2 和 Mcl-1 敲低增加了 CLL-CII 细胞对氟达拉滨的敏感性。
Asian Pac J Cancer Prev. 2021 Jul 1;22(7):2191-2198. doi: 10.31557/APJCP.2021.22.7.2191.
4
Knockdown of Myeloid Cell Leukemia-1 by MicroRNA-101 Increases Sensitivity of A549 Lung Cancer Cells to Etoposide.miR-101 通过下调髓样细胞白血病-1 增加 A549 肺癌细胞对依托泊苷的敏感性。
Iran J Med Sci. 2021 Jul;46(4):298-307. doi: 10.30476/ijms.2020.83173.1203.
5
Immunotherapy in AML: a brief review on emerging strategies.急性髓系白血病中的免疫疗法:新兴策略简述
Clin Transl Oncol. 2021 Dec;23(12):2431-2447. doi: 10.1007/s12094-021-02662-1. Epub 2021 Jun 23.
6
Alternative approaches to overcome chemoresistance to apoptosis in cancer.克服癌症细胞凋亡耐药性的替代方法。
Adv Protein Chem Struct Biol. 2021;126:91-122. doi: 10.1016/bs.apcsb.2021.01.005. Epub 2021 Mar 9.
7
/Survivin Expression as a Non-Invasive Biomarker of Endometriosis.生存素表达作为子宫内膜异位症的一种非侵入性生物标志物
Diagnostics (Basel). 2020 Jul 30;10(8):533. doi: 10.3390/diagnostics10080533.
8
Pairing MCL-1 inhibition with venetoclax improves therapeutic efficiency of BH3-mimetics in AML.联合 MCL-1 抑制与 venetoclax 可提高 AML 中 BH3 模拟物的治疗效果。
Eur J Haematol. 2020 Nov;105(5):588-596. doi: 10.1111/ejh.13492. Epub 2020 Aug 4.
9
Gene Therapy with MiRNA-Mediated Targeting of Mcl-1 Promotes the Sensitivity of Non-Small Cell Lung Cancer Cells to Treatment with ABT-737.通过miRNA介导靶向Mcl-1的基因治疗可提高非小细胞肺癌细胞对ABT-737治疗的敏感性。
Asian Pac J Cancer Prev. 2020 Mar 1;21(3):675-681. doi: 10.31557/APJCP.2020.21.3.675.
10
MiRNA-7 enhances erlotinib sensitivity of glioblastoma cells by blocking the IRS-1 and IRS-2 expression.miRNA-7 通过阻断 IRS-1 和 IRS-2 的表达增强胶质母细胞瘤细胞对厄洛替尼的敏感性。
J Pharm Pharmacol. 2020 Apr;72(4):531-538. doi: 10.1111/jphp.13226. Epub 2020 Feb 5.